SIRT3 and breast carcinoma: Some reports suggest that SIRT3 could have a crucial role in the development and progression of some types of cancer acting as a tumour promoter, such as breast cancer [46], colon cancer [30], gastric cancer [55], esophageal cancer [81], oral squamous cell carcinoma [82], melanoma [83], and renal cancer [58].